Galantamine hydrobromide 4 MG/ML Oral Solution — RxCUI 860901
RxNorm drug concept · Semantic clinical drug
RxCUI 860901
Semantic clinical drug · SCD
● Current RxNorm concept 1 FDA product
1 package NDC
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI860901
Official nameGalantamine hydrobromide 4 MG/ML Oral Solution
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asgalantamine HBr 4 MG per 1 ML Oral Solution; galantamine HBr 4 MG in 1 mL Oral Solution
FDA products mapped1
Package NDCs mapped1
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Galantamine: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- Galantamine helps boost a brain chemical called acetylcholine that Alzheimer's disease gradually depletes. This can help maintain memory and thinking for a period of time, but it d...
- What exactly does galantamine do for Alzheimer's — will it stop the disease from getting worse?
- Nausea and vomiting are the most common side effects, especially when the dose is being increased. The good news is that nausea usually only lasts about 5 to 7 days and tends to ge...
- I heard galantamine can upset your stomach — is there anything I can do about that?
🕸️ Concept Web — How Galantamine hydrobromide 4 MG/ML Oral Solution Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Galantamine hydrobromide 4 MG/ML Oral Solution
RxCUI 860901 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 2
The active substance itself — no strength, form, or brand attached yet.
-
Galantamine
4637IN -
Galantamine hydrobromide
860693PIN
-
Galantamine
-
Dose forms 9
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Galantamine Oral Solution
384642SCDF -
Galantamine hydrobromide Oral Solution
2646285SCDFP -
Galantamine Oral Liquid Product
1163353SCDG -
Galantamine Oral Product
1163354SCDG -
Galantamine hydrobromide Oral Liquid Product
2661530SCDGP -
Galantamine hydrobromide Oral Product
2661776SCDGP -
Oral Solution
316968DF -
Oral Liquid Product
1151137DFG - +1 more in this family
-
Galantamine Oral Solution
-
Clinical & branded drugs 1
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Galantamine hydrobromide 4 MG/ML
860900SCDC
-
Galantamine hydrobromide 4 MG/ML
Showing up to 8 concepts per family — 11 of 12 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Galantamine hydrobromide 4 MG/ML
SCDC · 860900 -
Galantamine Oral Solution
SCDF · 384642 -
Galantamine hydrobromide Oral Solution
SCDFP · 2646285 -
Galantamine Oral Liquid Product
SCDG · 1163353 -
Galantamine Oral Product
SCDG · 1163354 -
Galantamine hydrobromide Oral Liquid Product
SCDGP · 2661530 -
Galantamine hydrobromide Oral Product
SCDGP · 2661776
📦 FDA Products & Package NDCs
1 product · 1 package NDC
1 package NDC map to RxCUI 860901 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 00054-0137-49 | 100 mL in 1 BOTTLE (0054-0137-49) | Galantamine Hydrobromide | Hikma Pharmaceuticals USA Inc. | 2009-08-14 |
Observed labelers:
Hikma Pharmaceuticals USA Inc. (1)
— this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.